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Abstract  
 
Exposure to surface ozone (O3), which is influenced by emissions of precursor chemical 
species, meteorology and population distribution, is associated with excess mortality and 
respiratory morbidity. In this study, the EMEP-WRF atmospheric chemistry transport model 
was used to simulate surface O3 concentrations at 5 km horizontal resolution over the British 
Isles for a baseline year of 2003, for three anthropogenic emissions scenarios for 2030, and 
for a +5 °C increase in air temperature on the 2003 baseline. Deaths brought forward and 
hospitalization burdens for 12 UK regions were calculated from population-weighted daily 
maximum 8-hour O3. The magnitude of changes in annual mean surface O3 over the UK for 
+5 °C temperature (+1.0 to +1.5 ppbv, depending on region) were comparable to those due to 
inter-annual meteorological variability (−1.5 to +1.5 ppbv) but considerably less than changes 
due to precursor emissions changes by 2030 (−3.0 to +3.5 ppbv, depending on scenario and 
region). Including population changes in 2030, both the ‘current legislation’ and ‘maximum 
feasible reduction’ scenarios yield greater O3-attributable health burdens than the ‘high’ 
emission scenario: +28%, +22%, +16%, respectively, above 2003 baseline deaths brought 
forward (11,500) and respiratory hospital admissions (30,700), using O3 exposure over the 
full year and no threshold for health effects. The health burdens are greatest under the 
‘current legislation’ scenario because O3 concentrations increase as a result of both increases 
in background O3 concentration and decreases in UK NOx emissions. For the +5 °C scenario, 
and no threshold (and not including population increases), total UK health burden increases 
by 500 premature deaths (4%) relative to the 2003 baseline. If a 35 ppbv threshold for O3 
effects is assumed, health burdens are more sensitive to the current legislation and +5 °C 
scenarios, although total health burdens are roughly an order of magnitude lower. In all 
scenarios, the assumption of a threshold increases the proportion of health burden in the south 
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and east of the UK compared with the no threshold assumption. The study highlights that the 
total, and geographically-apportioned, O3-attributable health burdens in the UK are highly 
sensitive to the future trends of hemispheric, regional and local emissions of O3 precursors, 
and to the assumption of a threshold for O3 effect.  
 
Keywords: ozone; health impact assessment; future emissions scenarios; air pollution; 
climate change. 
 
 
1 Introduction  
 
Substantial epidemiological evidence exists quantifying acute effects of short-term exposure 
to ambient ozone (O3), particularly on mortality and respiratory hospital admissions (Bell et 
al., 2005; 2006; Levy et al., 2005; Ito et al., 2005; WHO, 2006). Ozone is a secondary 
pollutant which is not directly emitted into the atmosphere but is created and destroyed by 
chemical reactions of other emitted species. The most important of these precursors are 
methane (CH4) and carbon monoxide (CO), which have lifetimes of weeks to years and 
which, with emissions of nitrogen oxides (NOx = NO+NO2), contribute to a general 
hemispheric ‘background’ of O3, and non-methane volatile organic compounds (NMVOC) 
which influence O3 formation on a regional and local scale. When NOx emissions are very 
high, such as in urban areas, production of O3 is suppressed. Meteorology also substantially 
impacts on O3 via its influences on, for example, rates of chemical reactions, deposition of O3 
to the surface, emissions of biogenic  NMVOC, boundary-layer depth, stagnating air 
pollution episodes and long-range transport.   
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Ozone precursor emissions are changing, but with different individual precursor trends in 
different regions around the world, and consequently the relative ratios in precursor 
emissions are also changing in different ways in different regions (Royal Society, 2008; 
AQEG, 2009; Lamarque et al., 2010). Consequently, population exposure to O3 is changing 
(Royal Society, 2008; Colette et al., 2012; Coleman et al., 2013). Climate change also 
directly and indirectly modifies surface O3 through its influence on processes determining 
emissions, chemistry and dispersion (Royal Society, 2008; Jacob and Winner, 2009; Fiore et 
al., 2012; Langner et al., 2012; Fang et al., 2013; Doherty et al., 2013). Given these changes, 
it is pertinent to estimate how the health burdens associated with surface O3 may change in 
the future compared with recent levels, which is the focus of this work, for the UK 
specifically.  
 
Previous estimates of future surface O3 over the UK have generally been derived either from 
global models whose horizontal spatial resolutions are a few degrees (~200 km), or by semi-
empirical mapping methods (Stedman and Kent, 2008). In this study, a nested atmospheric 
chemistry transport model has been used to simulate hourly O3 concentrations at 5 km 
horizontal resolution across the British Isles for 2003, for three anthropogenic emissions 
scenarios for 2030, and for a simulation with increased surface temperature (as one sensitivity 
test for climate change). Simulated O3 changes are also set in the context of variability of 
surface O3 arising from two different years of meteorology. The impacts of these simulated 
changes in O3 on regional UK mortality and morbidity from short-term exposure are 
calculated both with and without inclusion of a threshold concentration for health effects, as 
recommended by the World Health Organisation (WHO, 2013). Health burdens from 
simultaneous changes in other air pollutant concentrations are not considered here. 
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2 Methods  
 
2.1 Atmospheric chemistry transport modelling 
 
The model used here is a grid-based, nested atmospheric chemistry transport model (ACTM) 
operating at 5 km by 5 km horizontal resolution over a British Isles inner domain (Vieno et 
al., 2010) derived from the (European Monitoring and Evaluation Programme) EMEP model 
(Simpson et al., 2012). The chemistry model is driven by the Weather Research Forecast 
(WRF) model at the same horizontal resolution. The WRF model is constrained by boundary 
conditions from the US National Center for Environmental Prediction/National Center for 
Atmospheric Research Global Forecast System at 1° resolution, every 6 hours. Simulations 
are achieved using a one-way nested domain approach in which modelling over an outer 
domain at 50 km resolution for Europe provides the boundary conditions for finer-scale 
modelling over the 5 km inner domain. The model has been extensively evaluated and used 
for numerous policy applications (Carslaw, 2011; Carslaw et al., 2013; Schultz et al., 2013). 
Emissions data, including biogenic emissions, were obtained from the UK National 
Atmospheric Emissions Inventory (naei.defra.gov.uk) for the inner domain covering the 
British Isles and from EMEP (www.emep.int) for the outer domain covering Europe. 
 
EMEP-WRF v3 simulations were performed using the following three air quality emissions 
projections, notionally for 2030, derived by the International Institute of Applied Systems 
Analysis (Dentener et al., 2005): 
(1) A2: a scenario based on the IPCC SRES A2 socioeconomic scenario (Nakicenovic et al., 
2000), which is generally regarded as ‘high’ for O3 precursor emissions, and assuming no 
additional implementation of air quality legislation;  
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(2) B2+CLE: a ‘current legislation’ scenario based on the IPCC SRES B2 socioeconomic 
scenario (Nakicenovic et al., 2000), which is one of the central SRES scenarios, often used as 
a baseline for global air quality studies (Stevenson et al., 2006), plus adherence to emissions 
reduction air quality legislation in force in year 2000; 
(3) B2+MFR: a ‘maximum feasible reduction’ scenario also based on the IPCC SRES B2 
scenario, but including reductions in emissions achievable through implementation of all 
abatement measures available in 2000, regardless of legislation or cost. 
 
Output from global multi-model simulations set the corresponding global CH4 abundance 
(Dentener et al., 2005), and the model outer domain O3 boundary conditions (Stevenson et 
al., 2006), appropriate for each scenario. This ensured that the concentrations of the longer-
lived CH4 and O3 species entering the UK domain were compatible with the emissions 
projections. The three scenarios span a useful range of potential emissions futures: the A2 
scenario sets a likely upper bound on emissions, whilst B2+MFR sets a likely lower bound. 
These scenarios do not include consideration of climate change. The emissions changes 
between 2000 and 2030 over the British Isles for the key O3 precursor species under each 
scenario are given in Table 1. No changes in the spatial distribution of emissions were 
applied.  
 
For the simulation to examine the O3 response to increased temperature, the 2003 base model 
run was repeated with surface and potential temperatures uniformly increased by 5 °C in the 
inner domain. Boundary conditions were not changed. The UKCP09 climate projections 
(ukclimateprojections.defra.gov.uk) indicate that under medium-to-high future greenhouse 
gas emission scenarios there is a medium-to-high probability of average summer temperature 
increases of 5 °C over most of the UK in the 2080s. Temperature increase is the only aspect 
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of climate change investigated here but temperature increase has important direct influence 
on rates of biogenic VOC emissions, gas-phase chemical reaction rates, and O3 dry 
deposition. Other effects of climate change, such as its influence on water vapour 
concentrations or atmospheric dispersion were not investigated.  
 
The baseline experiment was also repeated using 2004 meteorology to provide an indicator of 
the impact on surface O3 of a different year’s meteorology. 
 
2.2 Health burden assessment methodology 
 
Population health burdens attributable to short-term exposure to O3 were calculated as 
follows for the 12 UK administrative regions listed in Table 2:  
 
Daily mortality (or morbidity) = daily O3 × concentration-response coefficient × baseline 
mortality (or morbidity) rate × population 
 
In this work, ‘daily O3’ refers to the daily maximum running 8-hour mean, as widely used in 
O3 health effect studies. Residential population for 2003 at 100 m × 100 m resolution for 
England, Wales and Scotland were taken from the UK National Population Database 2 
(NPD2) (Smith et al., 2005) and aggregated to each EMEP-WRF 5 km × 5 km grid cell. 
Health burdens were calculated by multiplying the exposed population by the O3 
concentration in each model cell, then summing all cells within each administrative region, 
and dividing by the total regional population to give a population-weighted mean O3 
exposure per region. The NPD2 did not cover Northern Ireland, so geographical mean O3 
rather than population-weighted O3 was used. Population estimates for 2030 were derived by 
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linear interpolation between projections by the ONS (www.statisics.gov.uk) for 2026 and 
2031 (English regions) and 2028 and 2033 (Wales, Scotland and Northern Ireland). 
 
To quantify premature mortality, an all-cause mortality concentration-response coefficient of 
0.3% (95% confidence interval 0.1%−0.4%) per 10 µg m-3 increase in daily maximum 
running 8-hour mean O3 was used (0.6%, CI: 0.2%−0.8%) increase per 10 ppbv O3), as 
recommended by the World Health Organisation (WHO, 2004) and used in previous UK 
studies (Stedman and Kent, 2008; Hames and Vardoulakis, 2012). To quantify morbidity, a 
concentration-response coefficient of 1.4% (CI: 0.8%−2%) increase in respiratory hospital 
admissions per 10 ppbv increase in daily maximum running 8-hour mean O3 was used 
(COMEAP, 1998). (The latter CI is based on those for the European APHEA studies from 
which the COMEAP central estimate is derived.) The uncertainty in a health response 
coefficient, as characterised by its confidence interval, propagates linearly through the health 
burden calculation. Thus the confidence interval on the central estimate of any mortality 
health burden ranges from 33%−133% of the central estimate; the confidence interval of any 
respiratory hospital admission health burden ranges from 57%−143% of the given central 
estimate. Relative patterns of health burden across regions, scenarios and threshold 
assumptions are unaffected.  
 
Daily baseline mortality rates for all causes, excluding external, were calculated based on a 
mean of values for each day of the year between 1993 and 2006 and for each of the 12 
regions using data obtained from the ONS. Daily baseline morbidity data were not available, 
so an annual baseline morbidity rate (divided by 365) was used, derived from emergency 
respiratory hospital admissions between 2005 and 2008 obtained from NHS Hospital Episode 
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Statistics (www.hesonline.nhs.uk).  The same mortality and morbidity rates were assumed for 
2030. 
 
Current evidence of a threshold for health effects associated with short-term exposure to O3 is 
not consistent (WHO, 2013). Therefore, daily O3-attributable premature mortality and 
hospitalizations, for each UK region, were calculated assuming both no threshold, and a 
threshold of 35 ppbv (70 µg m-3) for O3 health effects, as is currently recommended 
(UNECE/WHO, 2004; WHO, 2013). Health burdens were summed for the whole year of 
exposure.   
 
3 Results  
 
3.1 Surface ozone concentrations 
3.1.1  Anthropogenic emissions scenarios  
Figure 1 illustrates the changes in annual mean surface O3 across the UK between 2003 and 
2030 for the three different emissions scenarios. The regional annual population-weighted 
means of the daily maximum 8-hour O3 for the baseline and three future scenarios are given 
in Table 2. In 2003 the highest annual O3 concentrations were predominately in the northern 
and western regions of the UK (Scotland, Northern Ireland, Wales and South West England) 
and the lowest concentrations were in the eastern regions associated with greatest 
urbanisation and higher NOx emissions (London, East Midlands, and Yorkshire and 
Humberside).  
 
For the future emissions scenarios, the key features from Figure 1 and Table 2 are: for the 
B2+CLE scenario, increases in annual O3 of 1.5-3 ppbv everywhere over the UK (up to 3.5 
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ppbv in London); for the A2 scenario, decreases over most of England (except the far north), 
reaching −2 ppbv in urban areas and −3 ppbv in the London area (Table 2), and increases of 
0-3 ppbv everywhere else; and, for the B2+MFR scenario, largely the reverse of the pattern 
under A2 (increases of 0-3 ppbv over most of England, plus south Wales, Edinburgh-
Glasgow and Belfast, and decreases up to −1.5 ppbv elsewhere).  
 
These changes in UK surface O3 reflect differences in the amount of background O3 
(approximately set by the boundary conditions in Table 1), in conjunction with differences 
due to changes in UK NOx emissions that influence the extent of O3 removal through reaction 
with NO in high NOx (i.e. urban) regions. Thus in the A2 scenario background O3 increases 
because of hemispheric increases in O3 precursors, including CH4 and CO, but the increased 
NOx emissions (primarily related to traffic density and power generation) lead to increased 
loss of O3 by reaction with NO. This effect is prominent over most major UK cities and areas 
of greatest population density (Figure 1). The greater annual mean surface O3 concentration 
over most of England for the B2+MFR scenario is due to the substantial reductions in NOx 
emissions causing a decrease in the loss of O3 by this chemical reaction; again a prominent 
feature over UK cities (Figure 1). These localised O3 increases are superimposed on the 
general decrease in background O3 in this scenario. The O3 changes are greatest under the 
B2+CLE scenario (Scotland excepted), since O3 concentrations increase because of both 
increases in background O3 concentration (as in the A2 scenario) and decreases in UK NOx 
emissions (as in the B2+MFR scenario) (Table 1).  
 
3.1.2 Temperature sensitivity  
The change in surface O3 for a +5 °C uniform increase in temperature for the whole year 
(compared with the 2003 baseline) is also shown in Figure 1. The +5 °C perturbation 
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increases annual mean surface O3 everywhere, with the largest increases (1.0-1.5 ppbv) in 
south and east England. Population-weighted annual mean daily maximum 8-hour O3 
increases in the south-east are up to 1.8 ppbv (Table 2). These changes in UK annual surface 
O3 due to a higher temperature are generally lower than potential changes due to 2030 
emissions changes although the higher temperature consistently yields increased surface O3.  
 
In these simulations it was not possible to quantify the key processes producing the O3 
increases; however simulations by Vieno et al. (2010) showed the main influence of elevated 
temperature on O3 in southern UK in August 2003 was via enhanced biogenic isoprene 
emission, although other factors such as dry deposition rate and transboundary import also 
contributed to the elevated O3 in this region at this time. Likewise, Doherty et al. (2013), in 
simulations for 2095 which included aspects of climate change, also showed the largest effect 
of temperature on surface O3 in mid-latitude polluted areas was through elevated isoprene 
emissions; but they also noted O3 increases resulting from enhanced decomposition of 
peroxyacetylnitrate (a temporary atmospheric reservoir species for NOx). In these polluted 
mid-latitude regions, the above effects continue to outweigh O3 decreases due to higher water 
vapour concentrations under simulated future climate to 2095.  
 
3.1.3 Inter-annual variability
 
Figure 2 shows that annual mean surface O3 was greater over much of southern England in 
2003, which included elevated O3 in August (Lee et al., 2006; Vieno et al., 2010), but was 
greater in 2004 over much of the northern UK. This illustration of the impact on surface O3 
from changes due to regional meteorology alone (−1.5 to +1.5 ppbv) can be compared with 
the general magnitude of impacts on surface O3 from potential changes in emissions to 2030 
(−3.0 to +3.5 ppbv, depending on scenario) shown in Figure 1. Whilst the O3 changes due to 
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inter-annual variability in meteorology are smaller they are nonetheless considerable, being 
up to ~50% (depending on scenario) of the changes projected to 2030 from anthropogenic 
emissions changes. They are also of comparable magnitude to those simulated for the +5 °C 
increase in temperature. Although only two meteorological years were investigated in this 
work, the range in inter-annual variability of surface O3 shown here (~8%) is comparable 
with a study of inter-annual variability of O3 over Europe for the period 1958-2003 which 
reported typical year-to-year variability over the UK of ~10% (Andersson and Langner, 
2007).   
 
3.2 Health burdens 
3.2.1 2003 baseline 
Premature mortality and morbidity health burdens in the UK attributable to O3 are given in 
Supplementary Information Tables S1 and S2, respectively. Regional health burden rates 
expressed per 100,000 population are also included. The regional mortality burdens are 
illustrated in Figure 3. When no threshold is assumed, a total of 11,500 deaths brought 
forward and 30,700 hospitalizations in 2003 are attributable to O3. Attributable health 
burdens are highest in the South East and North West regions (Figure 3a and Tables S1 & 
S2), where population is high (Table 2), but the underlying O3-attributable mortality and 
morbidity rates (Tables S1 & S2) are greatest in Scotland, Wales and the South West, where 
annual mean O3 concentrations are greatest (Table 2).  
 
If a threshold for O3 effects of 35 ppbv is assumed then total UK annual premature mortality 
attributable to O3 in 2003 drops dramatically from 11,500 (no threshold) to 1,160 (Figure 3b 
and Table S1). Similarly, O3-attributable hospitalizations in 2003 decrease from 30,700 to 
3,210 if a 35 ppbv threshold is assumed (Table S2). There is an important shift in the 
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geographical distribution of the health burdens if a threshold for O3 effect is assumed. 
Supplementary Information Figure S1 shows that more of the attributable health burden is 
distributed in the north of the UK relative to the south if no threshold is assumed, but more is 
distributed in the south if a 35 ppbv threshold is assumed, albeit that absolute burdens are 
about 10 times lower in the latter case.    
 
3.2.2 2030 projections 
The annual health burdens for premature mortality and morbidity attributable to O3 under the 
three different emissions scenarios are also given in Tables S1 and S2, and the mortality data 
are presented graphically in Figure 3. 
 
When no threshold for O3 health effect is assumed, all three 2030 scenarios project increased 
mortality and hospitalization in all regions compared with 2003, but the % changes varies 
markedly between regions. The greatest health burdens are associated with the B2+CLE 
scenario. This scenario gives increases in total UK premature mortality and hospitalizations 
of 3,200 and 8,400 respectively, which is a 28% increase on their 2003 values of 11,500 and 
30,700, respectively. These health burden increases are not only driven by the increase in UK 
population, which is 18% greater in 2030 than in 2003 (Table 2), but reflect the increase in 
surface O3 over most of the UK under this scenario (Figure 1). Regional health burden 
increases under the B2+CLE scenario vary between 16% for Scotland and 38% for East 
England. The A2 scenario projects a 16% increase in UK premature mortality and 
hospitalizations in 2030, with regional increases ranging between 8% for the North West and 
25% for Northern Ireland. The B2+MFR scenario projects a 22% increase in total UK health 
burden, with regional increases ranging between 9% for Scotland and 33% for East England 
and London. Thus, over the whole of the UK, both the ‘current legislation’ and ‘maximum 
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feasible reduction’ scenarios lead to greater total health burden from O3 in 2030 than the 
‘high’ emission A2 scenario. 
 
As well as giving the largest increase in total UK health burden attributable to O3, the 
B2+CLE scenario also leads to the largest health burden in every region except for Northern 
Ireland, whose health burden is slightly larger under the A2 scenario (Tables S1 & S2). In 
this western location the increase in background hemispheric O3 under the A2 scenario is 
slightly greater than the increase arising from declining regional NOx emissions (Figure 1). In 
contrast, the increase in mortality and hospitalization is larger for the B2+MFR scenario than 
for the A2 scenario in the more densely populated predominately eastern regions (London, 
the South East, East England and the East and West Midlands), whereas the increase in health 
burdens is smaller for the B2+MFR scenario than the A2 scenario for the less populated 
regions of Scotland, Northern Ireland and Wales. In fact, for these latter regions it is the 
increase in population that drives the increase in absolute health burdens under the B2+MFR 
scenario since mean surface O3 decreases in these regions under this scenario (Figure 1, and 
as discussed in Section 3.1).  
 
The impact of increased population is removed by examination of the annual O3-attributable 
mortality and morbidity rates per 100,000 population (Tables S1 & S2). The changes in these 
mortality rates between 2003 and 2030 for the different scenarios are illustrated in Figure 4. 
(Patterns in changes in hospitalizations are the same.) The B2+CLE scenario gives increases 
in mortality rate everywhere, and the largest increases in mortality rates of all scenarios 
investigated for all regions except Northern Ireland (Figure 4a). For the A2 scenario there is 
significant regional variation in changes in mortality rate, with substantial increases in 
Scotland and Northern Ireland, but substantial decreases in London, the South East and East 
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England (Figure 4a). Changes in mortality rate are generally smaller under the B2+MFR 
scenario, with small increases in the south and east of the UK, small decreases in Northern 
Ireland and almost no change in Scotland, Wales and the South West.  
 
When a 35 ppbv threshold is assumed, the total UK health burdens in 2030 for the three 
different scenarios are very roughly an order of magnitude lower compared with no threshold, 
but there are marked differences in the relative changes from the 2003 burdens (Figure 3 and 
Tables S1 & S2). With a 35 ppbv threshold assumption, there is a 52% increase in 
attributable mortality and morbidity on 2003 totals for the B2+CLE scenario compared with 
the 28% increase on 2003 totals for this scenario when no threshold is assumed. On the other 
hand, the A2 and B2+MFR scenarios both project smaller mortality and morbidity increases 
of, respectively, 8% and 13% for 2030 compared with 2003 than the 16% and 22% increases 
in 2030 for these two scenarios when no threshold is assumed. This reflects that the B2+CLE 
scenario increases surface O3 everywhere thereby increasing the number of days with daily 
maximum 8-hour O3 above 35 ppbv, whereas the A2 and B2+MFR scenarios have relatively 
more impact on the background O3 which is lower than 35 ppbv.   
 
As with the no threshold assumption, all regions show an increase in health burden rate for 
the B2+CLE scenario with a 35 ppbv threshold (Figure 4b), and this increase is again greatest 
out of the three scenarios in all regions except Northern Ireland where greatest increase in 
health burden rate is for the A2 scenario. For the A2 scenario and a 35 ppbv threshold, the 
less densely populated regions of Scotland, Northern Ireland and Wales (and, to less extent, 
North East and South West England) have increased health burden rate (Figure 4b), whilst all 
other regions have decreased health burden rate. Taking into account population changes, 
most regions have increased mortality and morbidity in 2030 under this scenario (Figure 3 
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and Tables S1 and S2) although London shows a significant decrease (−25%) because of the 
strong O3 decrease through reaction with NO in this densely urbanised region. For the 
B2+MFR scenario and a 35 ppbv threshold, everywhere except London and East England 
shows a decrease in O3 health burden rate in 2030 (Figure 4b); but after taking into account 
health burden changes due to projected population changes, only the more rural regions in the 
north and west of the UK such as Scotland, Northern Ireland, North East England and Wales 
have no change (or small decreases) in mortality and morbidity, whilst the other regions show 
an increase (Tables S1 and S2).  
 
In summary, if a threshold is assumed, health burden distributions under the B2+MFR 
scenario enhance the contrast between the more urbanised eastern and southern UK and the 
less densely populated Scotland, Northern Ireland and Wales. On the other hand, health 
burdens (with threshold) under the A2 scenario are more evenly distributed geographically.     
  
3.2.3 Temperature sensitivity 
The mortality burdens for the +5 °C perturbation (c.f. 2003 baseline) are presented in Figure 
3 and Table S3. Morbidity results (not shown) have similar trends. Since no changes in 
population are included in these data the changes in absolute numbers of health burden shown 
in Figure 3 and Table S3 directly reflect the changes in exposure to O3. Mortality rates per 
100,000 population are included to enable direct comparison with data in Table S1 for the 
three 2030 emissions scenarios. The changes in mortality rates from baseline are shown in 
Figure 4. 
 
Regardless of O3 threshold assumption, the health burden increases in the +5 °C temperature 
simulation for all regions of the UK, since surface O3 increases in all regions, although the 
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magnitude of increase varies by region (Figure 1 and Table 2). Under the assumption of no 
threshold for O3 health effect, total UK mortality increases by 500 premature deaths, or by 
4% on the baseline mortality of 11,500 (Figure 3a and Tables S1 & S2). The largest increases 
in health burden occur in the south eastern parts of the UK (Figure 1d) coincident with the 
highly populated regions of London, South East and East England and the smallest  increases 
occur in the North and West and less densely populated regions of the UK (Scotland, 
Northern Ireland and Wales). When a threshold for O3 health effect is assumed, the +5 °C 
scenario shows a proportionally much greater increase in total UK mortality of 30% above 
the 2003 baseline, but the absolute mortality numbers are again considerably lower than for 
the no threshold assumption (350 extra deaths brought forward above the corresponding 
baseline of 1,160) (Figure 3b). 
 
4  Discussion 
 
The three 2030 scenarios used here show that, depending on anthropogenic precursor 
emissions trends, surface O3 in different parts of the UK may increase or decrease. 
Background O3 is particularly influenced by global levels of CH4 and hence by CH4 controls 
(Stevenson et al., 2006; Wild et al., 2012). The B2+CLE scenario has increased background 
O3 (Table 1) but reductions in regional NOx. It is the reductions in UK NOx emissions which 
lead to localised increases in O3 in urban locations, especially over south-east England, due to 
reduced reactive removal with NO. This is consistent with the findings of Collete et al. 
(2012) for this region. The double effect of increased background and reduced removal by 
NO pushes more daily maximum 8-hour O3 concentrations over 35 ppbv for this scenario. 
For the B2+MFR scenario, although the lower NOx emissions lead to increased O3 in highly 
urbanised areas, the decrease in background O3 yields lower annual mean O3 and relatively 
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fewer days exceeding 35 ppbv compared with the B2+CLE scenario. The potential for 
different changes to mean and higher quantiles of O3 distribution caused by precursor 
emissions changes has been noted before (Vautard et al., 2006; Wilson et al., 2012; Colette et 
al., 2012).  
 
The range in changes of surface O3 over the UK across the three future emission scenarios 
investigated are larger than the changes simulated under a 5 °C increase in air temperature. 
However, the latter leads to an increase in surface O3 everywhere. Although it is not possible 
to make definitive statements regarding the relative influence of emissions scenarios versus 
climate change it is noted that the UKCP09 climate projections suggest that temperature 
increases of the order of 5 °C are not likely to occur until the 2080s, depending on 
greenhouse gas emission scenario followed (http://ukclimateprojections.defra.gov.uk). A 
number of recent regional modelling studies have also shown the effects of emissions 
changes on surface O3 in Europe to be generally larger than those due to climate change 
projected to 2100 (Coleman et al., 2013; Fang et al., 2013; Hedegaard et al., 2013). Hence, in 
the near term, the effects of precursor emission changes and inter-annual meteorological 
variability on annual-mean surface O3 are likely to outweigh the effects of changes in 
temperature or other effects of climate change.  
 
The total UK mortality and hospitalisation burdens presented here for 2003 are broadly 
comparable with earlier studies (Stedman and Kent, 2008; Hames and Vardoulakis, 2012) but 
there are differences in O3 modelling and baseline health rates used. A feature here was the 
use of daily O3 and health data and application of population-weighting to the individual 5 
km × 5 km grid O3 concentrations. The use of a daily baseline mortality rate rather than a 
single annual rate takes account of seasonal variations in mortality. The relative extent and 
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geographical distribution of adverse health burden of exposure to surface O3 follows the 
simulated O3 concentrations, but health burdens are also highly sensitive to whether a 
threshold concentration of O3 below which no health effect is assumed. When no threshold 
for a health effect of O3 is assumed, the annual total health burden from daily exposures is 
little affected by how the O3 concentration varies from day to day, but if a threshold is 
assumed then days of highest O3 contribute most to the estimated annual burden on health. 
Taking O3 exposure over the full year as relevant the health burdens with a 35 ppbv threshold 
are roughly an order of magnitude lower than if no threshold is assumed, but there is a 
relatively greater increase in health burden in the B2+CLE and +5°C temperature scenarios. 
The assumption of a threshold also enhances the geographical differences in health burdens: 
the B2+MFR scenario emphasises a health burden differential between the more urbanised 
eastern and southern UK and the less densely populated north and west, whilst for the A2 
scenario health burdens are more evenly distributed. 
 
It is important to recognise that the simulated O3 concentrations are derived from a single 
model, albeit a widely used and evaluated CTM (Carslaw, 2011; Carslaw et al., 2013; Schultz 
et al., 2013). Nevertheless, considerable inter-model variability in simulation of O3 has been 
noted elsewhere (Stevenson et al., 2006; Colette et al., 2012). The greatest uncertainties in 
simulated O3 pertinent to future scenarios relate to uncertainty in O3 precursor emissions, 
particularly from climate-sensitive biogenic sources (Guenther et al., 2012; Langner et al., 
2012) and in parameterisations of O3 dry deposition especially under drought conditions 
(Emberson et al., 2012). Many other potential meteorological influences of climate change 
may be relevant, including changes in humidity and in atmospheric transport and mixing 
processes, e.g. boundary layer depth, storm tracks and blocking highs. However, as 
highlighted above, future changes in anthropogenic emissions are generally found to be more 
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important than changes in meteorology for changes in mean surface O3 (Fiore et al., 2012; 
Hedegaard et al., 2013) and in O3 exceedences (Coleman et al., 2013).  
 
Different health burden attribution methodologies may also yield different results. For 
example, there are uncertainties in the magnitude of concentration-response coefficients. 
Coefficients used here are derived from consideration of (mainly) full-year time series studies 
that focus on short-term population exposure to O3, and in this work O3 exposure over the full 
year was considered, a position supported by a recent review (WHO, 2013). Issues 
surrounding potential modification of the health effect of O3 by temperature are unresolved 
(Filleul et al., 2006; Ren et al., 2008; Pattenden et al., 2010; Atkinson et al., 2012). 
Complications also arise due to seasonally-varying correlations between O3 and other air 
pollutants with health effects, particularly particulate matter (PM). However, most studies 
find the effects of O3 are relatively independent of those of PM (WHO, 2006). It has been 
assumed that regional daily baseline mortality and morbidity rates remain constant in the 
future. Coefficients and threshold values were applied equally to all UK population 
demography, and to future populations. Regarding the latter, it is not possible to predict with 
certainty changes in concentration-response coefficients and threshold effects of any 
autonomous or planned adaptation to future O3 levels or to future climate change (Knowlton 
et al., 2004).  
 
5 Conclusions 
 
Under future emissions scenarios, simulated concentrations of surface O3 in the UK are 
highly sensitive to the interplay between levels of hemispheric background O3 and, especially 
in urban locations, the magnitude of local NOx emissions. Potential changes in surface O3 due 
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to precursor emissions changes by 2030 are larger in magnitude (−3.0 to +3.5 ppbv, 
depending on scenario assumed) than those due to inter-annual variability from 
meteorological influences (−1.5 to +1.5 ppbv), and also larger than the surface O3 increases 
under a +5 °C temperature scenario (1.0 to 1.5 ppbv, depending on geographic area).  
 
Including estimated population increases, both the B2+CLR ‘current legislation’ and 
B2+MFR ‘maximum feasible reduction’ emissions scenarios lead to greater UK health 
burden attributable to O3 in 2030 than the A2 ‘high’ emissions scenario: increases in deaths 
brought forward or hospitalisations on 2003 values of  28%, 22% and 16% for the three 
scenarios, respectively. Geographical contrasts are particularly notable between the densely 
populated areas in the south east of the UK and the more rural regions in the north and west. 
For all scenarios, relatively more of the O3 health burden is distributed in the north and west 
UK if no threshold for O3 health effects is assumed, and relatively more in the south and east 
if a threshold of 35 ppbv is assumed, but total health burdens are roughly an order of 
magnitude lower for the latter. 
 
Under a +5 °C temperature perturbation (and not including changes in other meteorological 
variables or population) total modelled UK health burden increases by 4% (corresponding to 
500 additional deaths brought forward), if no O3 threshold is assumed, or by 30% (350 
additional deaths brought forward) for a 35 ppbv threshold. These data reflect that the impact 
of increased temperature is to increase the instances of daily O3 above 35 ppbv.   
 
Overall, this study highlights that total, and geographically-distributed, O3-attributable health 
burdens in the UK are highly sensitive to the future trends in hemispheric, regional and local 
emissions of O3 precursors, and to the assumption of a threshold for O3 health effects. It is an 
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important issue for policy-makers that maintaining the status quo on airshed management is 
in some areas unlikely to reduce surface O3 and that a more customised analysis of the 
VOC/NOx regime is required.  
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Table 1: Percentage changes in annual anthropogenic emissions between 2000 and 2030 for 
the EMEP-WRF British Isles inner domain, and the changes in CH4 and average O3 mixing 
ratios at the inner domain boundary over their 2003 values given in parentheses. 
 
 
      A2 scenario B2+CLE scenario B2+MFR scenario 
∆NOx emissions +43% −20% −43% 
∆CO emissions +13% 
−49% −57% 
∆VOC emissions +49% 
−14% −26% 
∆CH4 concentrations 
(1760 ppbv) 
+403 ppbv +328 ppbv 0 ppbv 
∆O3 concentrations at model 
boundary (annual mean) 
(39.5 ppbv) 
+5.8 ppbv +2.7 ppbv 
−1.8 ppbv 
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Table 2. UK administrative regions and their populations in 2003 and 2030. Also included are 
the regional population-weighted annual mean daily maximum 8-hour O3 concentrations 
from EMEP-WRF simulations for 2003 (baseline year), and the changes in the population-
weighted O3 concentrations for +5 °C temperature sensitivity on the baseline year, and for 
projections for 2030 for the A2, B2+CLE and B2+MFR emissions scenarios. Regions are 
ordered approximately from north and west UK to south and east UK. 
 
 
 2003  2030 emissions scenarios  +5 °C  
c.f. 2003 
Region Population (1000s) 
Baseline 
O3 
(ppbv) 
 Population 
(1000s) 
A2 
∆O3 
(ppbv) 
B2+CLE 
∆O3 
(ppbv) 
B2+MFR 
∆O3 
(ppbv) 
 +5 °C 
∆O3 
(ppbv) 
Scotland – SC 5,057 33.1  5,522 1.6 2.2 -0.1  0.9 
Northern Ireland – NI 1,703 34.9  1,998 2.3 1.9 -1  0.7 
North West – NW 6,799 31.5  7,411 -0.4 2.8 1.2  1.2 
North East – NE 2,540 32.7  2,804 0.4 2.5 0.5  1.2 
Yorkshire & Humberside –YH  5,029 31.4  6,180 -0.8 2.8 1.3  1.4 
Wales – WA 2,929 35.4  3,313 0.7 2.2 -0.1  1.2 
West Midlands – WM 5,310 32.2  6,037 -0.8 2.7 1.1  1.5 
East Midlands – EM 4,254 32.3  5,237 -1.1 2.7 1.1  1.6 
South West – SW 5,003 36.4  6,197 -0.1 2.2 -0.1  1.5 
East England – EE 5,468 33.1  6,963 -1.9 2.8 1.4  1.8 
South East –SE 8,080 35.0  9,859 -1.8 2.4 0.7  1.8 
London – LN 7,380 31.2  9,029 -3.1 3.1 2.5  1.8 
Total population 59,552   70,550      
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Figure 1: Changes in annual mean surface O3 (ppbv) in 2030 for emissions scenarios A2 (top 
left), B2+CLE (top right) and B2+MFR (bottom left), and for a +5°C increase in temperature 
applied uniformly for the whole year within the British Isles inner model domain (bottom 
right), all relative to baseline meteorological year 2003.  
  
 
 
 30
Figure 2: Example impact of meteorological variability on annual mean surface O3 (ppbv) 
simulated by EMEP-WRF (year 2004 meteorology – year 2003 meteorology).  
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Figure 3:  UK annual deaths brought forward attributable to O3 for the 2003 baseline, a +5 °C 
temperature perturbation on baseline, and projections for 2030 under the A2, B2+CLE and 
B2+MFR emissions scenarios. The latter include estimated 2030 populations. (a, upper): 
assuming no threshold for O3 effect; (b, lower): assuming a 35 ppbv threshold for O3 effect. 
Note the sensitivity of absolute health burden values on uncertainty in the assumed health 
response coefficient, as discussed in Section 2.2; relative patterns of health burden across 
regions, scenarios and threshold assumptions are unaffected. 
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Figure 4. Changes in regional annual mortality rate per 100,000 population between 2003 and 
2030 for the three emissions projection scenarios and assumptions of no threshold (a, upper) 
and 35 ppbv threshold (b, lower) for O3 effects. The regions are ordered left to right 
approximately geographically from the north and west of the UK to the south and east. Note 
the sensitivity of absolute health burden rates on uncertainty in the assumed health response 
coefficient, as discussed in Section 2.2; relative patterns of health burden rates across regions, 
scenarios and threshold assumptions are unaffected. 
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Figure S1: Proportion by UK region of total UK deaths brought forward attributable to O3 in 
2003, for assumptions of no threshold and 35 ppbv threshold for effect of O3. The regions are 
ordered left to right approximately geographically from the north and west of the UK to the 
south and east. Proportionally more of the health burden is distributed in the north and west 
(i.e. regions plotted to the left of the figure) if no threshold is assumed, but proportionally 
more is distributed in the south and east (to the right of the figure) if the threshold is assumed. 
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Table S1: Regional and total UK annual deaths brought forward attributable to O3, assuming no threshold and a 35 ppbv threshold, for the 2003 
baseline and for 2030 projections under the A2, B2+CLE and B2+MFR emissions scenarios (including estimated populations for 2030). The 
annual deaths brought forward per 100,000 population for each region and each scenario are provided in parentheses. Individual data are 
presented to a maximum of 3 significant figure. 
 
 Annual deaths brought forward (& rate per 100,000), no threshold  Annual deaths brought forward (& rate per 100,000), with 35 ppbv threshold 
 2003 2030  2003 2030 
 Baseline A2 B2+CLE B2+MFR  baseline A2 B2+CLE B2+MFR 
Region mortality (rate) 
mortality 
(rate) 
% 
mortality 
change 
mortality 
(rate) 
% 
mortality 
change 
mortality 
(rate) 
% 
mortality 
change 
 
mortality 
(rate) 
mortality 
(rate) 
% 
mortality 
change 
mortality 
(rate) 
% 
mortality 
change 
mortality 
(rate) 
% 
mortality 
change 
SC 1110 (22.0) 
1270 
(23.1) 
14.4 1300 
(23.5) 
16.4 1210 
(22.0) 
8.8 
 79 
(1.56) 
117 
(2.11) 
48.1 116 
(2.10) 
46.8 70 
(1.28) 
-11.4 
NI 296 (17.4) 
371 
(18.6) 
25.3 366 
(18.3) 
23.6 338 
(16.9) 
14.2 
 24 
(1.41) 
45 
(2.26) 
87.5 38 
(1.89) 
58.3 22 
(1.08) 
-8.3 
NW 1360 (20.0) 
1470 
(19.8) 
7.9 1620 
(21.8) 
18.7 1540 
(20.8) 
13.2 
 106 
(1.57) 
105 
(1.42) 
-0.9 156 
(2.11) 
47.2 114 
(1.53) 
7.5 
NE 543 (21.4) 
606 
(21.6) 
11.6 645 
(23.0) 
18.8 609 
(21.7) 
12.2 
 44 
(1.72) 
52 
(1.87) 
18.2 65 
(2.31) 
47.7 43 
(1.55) 
-2.3 
YH 950 (18.9) 
1140 
(18.4) 
19.9 1270 
(20.6) 
34.0 1220 
(19.7) 
28.2 
 76 
(1.52) 
79 
(1.27) 
3.9 127 
(2.05) 
67.1 93 
(1.51) 
22.4 
WA 677 (23.1) 
782 
(23.6) 
15.5 815 
(24.6) 
20.4 765 
(23.1) 
13.0 
 72 
(2.45) 
95 
(2.86) 
31.9 104 
(3.14) 
44.4 72 
(2.16) 
0.0 
WM 1000 (18.8) 
1110 
(18.4) 
10.9 1230 
(20.4) 
23.2 1180 
(19.5) 
17.8 
 98 
(1.84) 
98 
(1.63) 
0.0 143 
(2.37) 
45.9 107 
(1.77) 
9.2 
EM 788 (18.5) 
939 
(17.9) 
19.2 1050 
(20.1) 
33.6 1010 
(19.2) 
27.7 
 82 
(1.94) 
84 
(1.60) 
2.4 130 
(2.49) 
58.5 98 
(1.87) 
19.5 
SW 1140 (22.9) 
1410 
(22.8) 
23.5 1500 
(24.2) 
31.1 1410 
(22.8) 
23.5 
 143 
(2.87) 
181 
(2.92) 
26.6 216 
(3.49) 
51.0 156 
(2.52) 
9.1 
EE 998 (18.2) 
1200 
(17.2) 
20.2 1380 
(19.8) 
38.3 1330 
(19.1) 
33.1 
 113 
(2.07) 
103 
(1.48) 
-8.8 187 
(2.68) 
65.5 147 
(2.11) 
30.1 
SE 1600 (19.8) 
1860 
(18.8) 
16.1 2090 
(21.2) 
30.5 1997 
(20.3) 
24.7 
 208 
(2.58) 
203 
(2.05) 
-2.4 303 
(3.08) 
45.7 236 
(2.39) 
13.5 
LN 1060 (14.3) 
1170 
(12.9) 
10.7 1430 
(15.8) 
35.0 1400 
(15.5) 
32.8 
 116 
(1.57) 
87 
(0.96) 
-25.0 175 
(1.94) 
50.9 149 
(1.65) 
28.4 
TOTAL 11,500 13,300 15.6 14,700 27.7 14,000 21.5  1,160 1,250 7.5 1,760 51.5 1,310 12.5 
 
 
 35
Table S2: Regional and total UK annual respiratory hospitalizations attributable to O3, assuming no threshold and a 35 ppbv threshold, for the 
2003 baseline and for 2030 projections under the A2, B2+CLE and B2+MFR emissions scenarios (including estimated populations for 2030). 
The annual hospitalizations per 100,000 population for each region and each scenario are provided in parentheses. Individual data are presented 
to a maximum of 3 significant figure. 
 
 Annual hospitalizations (& rate per 100,000), no threshold  Annual hospitalizations (& rate per 100,000), with 35 ppbv threshold 
 2003 2030  2003 2030 
 baseline A2 B2+CLE B2+MFR  baseline A2 B2+CLE B2+MFR 
Region morbidity (rate) 
morbidity 
(rate) 
% 
morbidity 
change 
morbidity 
(rate) 
% 
morbidity 
change 
morbidity 
(rate) 
% 
morbidity 
change 
 
morbidity 
(rate) 
morbidity 
(rate) 
% 
morbidity 
change 
morbidity 
(rate) 
% 
morbidity 
change 
morbidity 
(rate) 
% 
morbidity 
change 
SC 2530 (50.0) 
2900 
(52.5) 
14.4 2950 
(53.4) 
16.4 2750 
(50.0) 
8.8 
 186 
(3.7) 
272 
(4.9) 
48.1 272 
(4.9) 
46.8 166 
(3.0) 
-11.4 
NI 1150 (67.7) 
1440 
(72.2) 
25.3 1420 
(71.2) 
23.6 1310 
(65.6) 
14.2 
 96 
(5.6) 
178 
(8.9) 
87.5 149 
(7.4) 
58.3 86 
(4.2) 
-8.3 
NW 3900 (57.3) 
4190 
(56.6) 
7.9 4620 
(62.3) 
18.7 4400 
(59.4) 
13.2 
 316 
(4.7) 
308 
(4.2) 
-0.9 463 
(6.3) 
47.2 338 
(4.5) 
7.5 
NE 1240 (49.0) 
1390 
(49.5) 
11.6 1480 
(52.6) 
18.8 1390 
(49.6) 
12.2 
 104 
(4.1) 
123 
(4.4) 
18.2 153 
(5.4) 
47.7 103 
(3.7) 
-2.3 
YH 2590 (51.6) 
3100 
(50.0) 
19.9 3470 
(56.1) 
34.0 3320 
(53.6) 
28.2 
 216 
(4.3) 
220 
(3.5) 
3.9 358 
(5.8) 
67.1 265 
(4.3) 
22.4 
WA 1620 (55.3) 
1870 
(56.4) 
15.5 1950 
(58.9) 
20.4 1830 
(55.2) 
13.0 
 178 
(6.1) 
232 
(7.0) 
31.9 257 
(7.8) 
44.4 177 
(5.3) 
0.0 
WM 2740 (51.4) 
3030 
(50.2) 
10.9 3370 
(55.7) 
23.2 3210 
(53.2) 
17.8 
 278 
(5.2) 
276 
(4.6) 
0.0 408 
(6.8) 
45.9 305 
(5.0) 
9.2 
EM 2360 (55.4) 
2810 
(53.5) 
19.2 3150 
(60.1) 
33.6 3010 
(57.4) 
27.7 
 256 
(6.1) 
260 
(5.0) 
2.4 405 
(7.8) 
58.5 305 
(5.8) 
19.5 
SW 2950 (59.1) 
3640 
(58.8) 
23.5 3860 
(62.4) 
31.1 3630 
(58.7) 
23.5 
 383 
(7.7) 
479 
(7.7) 
26.6 577 
(9.3) 
51.0 417 
(6.7) 
9.1 
EE 2550 (46.4) 
3060 
(43.8) 
20.2 3520 
(50.5) 
38.3 3380 
(48.6) 
33.1 
 301 
(5.5) 
271 
(3.9) 
-8.8 496 
(7.1) 
65.5 391 
(5.6) 
30.1 
SE 3870 (47.8) 
4480 
(45.3) 
16.1 5040 
(51.2) 
30.5 4820 
(48.9) 
24.7 
 525 
(6.5) 
507 
(5.1) 
-2.4 765 
(7.8) 
45.7 596 
(6.0) 
13.5 
LN 3210 (43.5) 
3540 
(39.1) 
10.7 4320 
(47.9) 
35.0 4240 
(46.9) 
32.8 
 366 
(5.0) 
273 
(3.0) 
-25.0 552 
(6.1) 
50.9 472 
(5.2) 
28.4 
TOTAL 30,700 35,400 15.6 39,100 27.7 37,300 21.5  3,210 3,400 7.5 4,860 51.5 3,620 12.5 
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Table S3. Regional and total UK annual deaths brought forward attributable to O3, assuming 
no threshold and a threshold of 35 ppbv, for a +5 °C temperature perturbation compared with 
the 2003 baseline. Deaths brought forward per 100,000 population are given in parentheses. 
Individual data are presented to a maximum of 3 significant figure.  
 
 
 
Annual deaths brought forward, no 
threshold 
Annual deaths brought forward, with 
35 ppbv threshold 
Region 2003 baseline +5 °C temp % change 2003 baseline +5 °C temp % change 
SC 1110 (22.0) 
1140 
(22.6) 2.4 
79 
(1.6) 
98 
(1.9) 24.5 
NI 296 (17.4) 
302 
(17.7) 1.9 
24 
(1.4) 
28 
(1.6) 16.5 
NW 1360 (20.0) 
1410 
(20.8) 3.7 
106 
(1.6) 
139 
(2.0) 30.8 
NE 543 (21.4) 
562 
(22.1) 3.6 
44 
(1.7) 
57 
(2.2) 29.7 
YH 950 (18.9) 
988 
(19.7) 4.0 
76 
(1.5) 
101 
(2.0) 33.0 
WA 677 (23.1) 
700 
(23.9) 3.3 
72 
(2.5) 
89 
(3.0) 23.9 
WM 1000 (18.8) 
1040 
(19.6) 4.2 
98 
(1.8) 
128 
(2.4) 31.0 
EM 788 (18.5) 
824 
(19.4) 4.5 
82 
(1.9) 
108 
(2.5) 31.2 
SW 1140 (22.9) 
1190 
(23.7) 3.8 
143 
(2.9) 
178 
(3.6) 24.4 
SE 1600 (19.8) 
1680 
(20.8) 4.9 
208 
(2.6) 
270 
(3.3) 29.6 
EE 998 (18.2) 
1050 
(19.2) 5.2 
113 
(2.1) 
152 
(2.8) 34.3 
LN 1060 (14.3) 
1120 
(15.1) 5.5 
116 
(1.6) 
156 
(2.1) 34.7 
TOTAL 11,500 12,000 4.1 1,160 1,510 29.5 
 
 
 
